Featured products include the Cytation 5 cell imaging multimode readerfrom BioTek, an ebola disinfectant from Mueller Sports Medicine, and a lab coat with multiple pockets for electronic devices from ScotteVest.
While automation has long been regarded as an important means for clinical laboratories to achieve greater efficiency and accuracy, some laboratories have in the past been slow to adopt automation as a broad strategy.
The settlement between Illumina and Sequenom creates a pool for joint use of the companies’ intellectual properties in noninvasive prenatal testing.
Abbott says its latest platform has the potential to change how serious infections are detected and identified, providing doctors with information needed to start treating critically ill patients sooner, and reducing inappropriate use of broad-spectrum antibiotics.
FDA has granted CLIA-waived status to the Alere Determine HIV-1/2 Ag/Ab Combo test, making it eligible for use in physician offices and clinics. The fourth-generation test enables faster detection, within days of infection.
The ATUMtome, an automated tape-collecting ultramicrotome from RMC Products and Zeiss, uses an innovative tape collecting method that facilitates the efficient sectioning and handling of large volumes of biological samples for 3-D image reconstruction.
The Binding Site, a specialist protein company based in the United Kingdom, and eBioscience, an Affymetrix business, have announced a multiyear distribution agreement granting the Binding Site exclusive rights to distribute eBioscience’s analyte-specific reagents and CE-marked clinical flow cytometry reagents to hospitals and reference labs.
Bio-Rad Laboratories has received FDA premarket approval for its Geenius HIV-1/HIV-2 supplemental assay, which can differentiate circulating antibodies to human immunodeficiency virus types 1 and 2 in whole blood, serum, and plasma. Requiring little training, the test produces results within 30 minutes.
Bio-Hazard wipes from Current Technologies absorb specimen contents and sputum, while an orange plastic backing prevents splash or leakage from transferring to gloves.
With its acquisition of Ariosa Diagnostics, Roche enters the market for noninvasive prenatal testing and cell-free DNA testing services.